Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology. IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients
Aucun commentaire:
Enregistrer un commentaire